Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, rapid PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
It’s important to differentiate bacterial vaginosis (BV) from aerobic vaginitis (AV), an ongoing challenge with traditional methods. A molecular testing solution based on different bacterial combinations may allow distinction of BV versus AV, which has clinical significance with respect to treatment and care. This webinar presents a solution that could be employed to mitigate misdiagnosis of AV for BV.